PharVision Advisers’s Enerpac Tool Group EPAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,407
Closed -$222K 775
2025
Q3
$222K Buy
+5,407
New +$218K 0.12% 422
2025
Q2
Sell
-6,184
Closed -$277K 318
2025
Q1
$277K Buy
+6,184
New +$274K 0.38% 109

Other funds holding EPAC

PharVision Advisers's EPAC Position: Q4 2025 in Review

PharVision Advisers sold out of Enerpac Tool Group (EPAC) in Q4 2025, closing a stake of 5,407 shares — an estimated $222K sold.

PharVision Advisers first reported a position in EPAC in Q1 2025 and held it in 2 quarters. The position peaked at $277K in Q1 2025. 255 funds tracked by Wall St. Rank hold EPAC as of Q4 2025.

  • PharVision Advisers reported no remaining Enerpac Tool Group position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 5,407 Enerpac Tool Group shares in Q4 2025, an estimated $222K.
  • PharVision Advisers first reported a position in Enerpac Tool Group in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Enerpac Tool Group position peaked at $277K in Q1 2025.
  • 255 funds tracked by Wall St. Rank held Enerpac Tool Group as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.